BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32028328)

  • 21. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
    Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk.
    Bi J; Zheng X; Chen Y; Wei H; Sun R; Tian Z
    Hepatology; 2014 Oct; 60(4):1389-98. PubMed ID: 24912841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection.
    Biassoni R; Fogli M; Cantoni C; Costa P; Conte R; Koopman G; Cafaro A; Ensoli B; Moretta A; Moretta L; De Maria A
    J Immunol; 2005 May; 174(9):5695-705. PubMed ID: 15843571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies.
    Hasan MF; Campbell AR; Croom-Perez TJ; Oyer JL; Dieffenthaller TA; Robles-Carrillo LD; Cash CA; Eloriaga JE; Kumar S; Andersen BW; Naeimi Kararoudi M; Tullius BP; Lee DA; Copik AJ
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38081778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4
    Holder KA; Burt K; Grant MD
    Clin Transl Immunology; 2021; 10(10):e1348. PubMed ID: 34707863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
    Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P
    Front Immunol; 2018; 9():474. PubMed ID: 29616021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFN-γ Production, Dichotomous to TIGIT, in HIV-1 Infection.
    Motamedi M; Shahbaz S; Fu L; Dunsmore G; Xu L; Harrington R; Houston S; Elahi S
    Immunohorizons; 2019 Nov; 3(11):531-546. PubMed ID: 31732662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perturbed CD8
    Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
    Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.
    Zhang Q; Bi J; Zheng X; Chen Y; Wang H; Wu W; Wang Z; Wu Q; Peng H; Wei H; Sun R; Tian Z
    Nat Immunol; 2018 Jul; 19(7):723-732. PubMed ID: 29915296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy.
    Lupo KB; Yao X; Borde S; Wang J; Torregrosa-Allen S; Elzey BD; Utturkar S; Lanman NA; McIntosh M; Matosevic S
    Nat Commun; 2024 Mar; 15(1):1909. PubMed ID: 38429294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals.
    Wang F; Hou H; Wu S; Tang Q; Liu W; Huang M; Yin B; Huang J; Mao L; Lu Y; Sun Z
    Eur J Immunol; 2015 Oct; 45(10):2886-97. PubMed ID: 26171588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells.
    Zhao NQ; Ferreira AM; Grant PM; Holmes S; Blish CA
    Front Immunol; 2020; 11():829. PubMed ID: 32477342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis.
    Liu G; Zhang Q; Yang J; Li X; Xian L; Li W; Lin T; Cheng J; Lin Q; Xu X; Li Q; Lin Y; Zhou M; Shen E
    Cancer Immunol Immunother; 2022 Feb; 71(2):277-287. PubMed ID: 34129052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.
    Ward J; Bonaparte M; Sacks J; Guterman J; Fogli M; Mavilio D; Barker E
    Blood; 2007 Aug; 110(4):1207-14. PubMed ID: 17513617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
    Cho MM; Song L; Quamine AE; Szewc F; Shi L; Ebben JD; Turicek DP; Kline JM; Burpee DM; Lafeber EO; Phillips MF; Ceas AS; Erbe AK; Capitini CM
    bioRxiv; 2024 Jun; ():. PubMed ID: 37333207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.